Skip to main content
. 2014 Sep 11;2014(9):CD002018. doi: 10.1002/14651858.CD002018.pub2

Appleby 1997.

Methods Randomisation method: computer‐generated random numbers
Analysis by ITT: yes (LOCF), in addition to analysis by completion
Power calculation: none stated
Participants Setting: community‐based: women on maternity wards were asked to allow assessment of their mood in their homes 6‐8 weeks later
Country: UK
Inclusion criteria: women who scored ≥ 10 on the EPDS at the screening visit were assessed with the CIS‐R and eligible to participate if they scored ≥ 12, as well as satisfying research diagnostic criteria for major or minor depressive disorder
Exclusion criteria: chronic (> 2 years) or resistant depression, current drug or alcohol misuse, severe illness requiring close monitoring or hospital admission, breastfeeding
Number recruited: 87
Number dropped out: 26
Number analysed: 87 (additional completers analysis with 61 participants)
Age (mean): fluoxetine + 1 counselling session 25.7 years; fluoxetine + 6 counselling sessions 26.6 years; placebo + 1 counselling session 23.1 years; placebo + 6 counselling sessions 26.0 years
Ethnicity: no details
Socioeconomic status: no details
Interventions Women were randomly assigned to 1 of 4 groups:
  • Fluoxetine + 1 session of counselling (22 women)

  • Fluoxetine + 6 sessions of counselling (21 women)

  • Placebo + 1 session of counselling (23 women)

  • Placebo + 6 sessions of counselling (21 women)


Counselling was derived from CBT and structured to offer reassurance and practical advice on areas of concern to depressed mothers
Outcomes Assessments were carried out at week 1, 4 and 12
Outcome was effect on depressive symptoms as measured by mean scores on the CIS‐R, the HAM‐D (week 1 and 12 only) and the EPDS
Notes Funding source not given.
See footnote for abbreviations and description of outcome measures.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "Subjects were allocated to one of four treatment groups by using computer generated random numbers"
Allocation concealment (selection bias) Unclear risk No details on allocation concealment given
Blinding (performance bias and detection bias) 
 of participants Low risk "The counselling was delivered by a psychologist… supervised by a second psychiatrist, both were blind to drug treatment, as were trial subjects"
Blinding (performance bias and detection bias) 
 of personnel Low risk "The counselling was delivered by a psychologist… supervised by a second psychiatrist, both were blind to drug treatment, as were trial subjects"
Blinding (performance bias and detection bias) 
 of outcome assessors Low risk "The assessment interviews were conducted by a psychiatrist blind to subject treatment group"
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk "Drop‐out rates were similar in the four groups. Drop outs were younger than subjects who completed the study and more likely to have an unemployed partner and to have a planned pregnancy, but the groups did not differ on initial psychiatric morbidity scores, employment, obstetric complications, parity, family history, or personal history of depression, including postnatal depression"
Of 87 total participants, 14/43 from the fluoxetine plus counselling group dropped out and 12/44 of the placebo plus counselling group dropped out
Details of dropout timings and reasons were reported, but mainly "no reason given". Lack of improvement was the reason for 3 drop‐outs in the fluoxetine group but 0 in the placebo group. In contrast, 3 women in the placebo group but only 1 woman in the intervention group dropped out due to side effects
Selective reporting (reporting bias) Unclear risk Protocol unavailable
Other bias Unclear risk No details given on adherence to medication
See footnote for abbreviations and description of outcome measures